{"id":786508,"date":"2023-09-27T13:40:36","date_gmt":"2023-09-27T17:40:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/"},"modified":"2023-09-27T13:40:36","modified_gmt":"2023-09-27T17:40:36","slug":"tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/","title":{"rendered":"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WALTHAM, Mass., Sept.  27, 2023  (GLOBE NEWSWIRE) &#8212; TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the acceptance of six abstracts at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting, being held from November 1-5, 2023, both in San Diego, CA and virtually.<\/p>\n<p align=\"justify\">\n        <strong>Presentation Details:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>Product Characteristics and Clinical Trial Design for T-Plex, a Multiplexed, Enhanced T cell Receptor-Engineered T cell Therapy for Solid Tumors<br \/><strong>Authors: <\/strong>Shrikanta Chattopadhyay, Antoine J Boudot, Ribhu Nayar, Hannah Bader, Andrew Ferretti, Tary Traore, Nancy Nabilsi, Jenny Tadros, Badr Kiaf, Yifan Wang, Victor Ospina, Alok Das Mahopatra, Zhonghua Zhu, Qikai Xu, Krista Daniels, Briana Zimmerman, Mollie Jurewicz, Amanda Kordosky, Chris Malcuit, Yun Wang, Marlyane Motta, Jim Murray, Ray Lockard, Cagan Gurer, Debora Barton, Gavin MacBeath<br \/><strong>Abstract Number: <\/strong>709<br \/><strong>Date &amp; Time: <\/strong>Friday, November 3, 2023, 9:00 a.m. \u2013 7:00 p.m. PT<br \/><strong>Location: <\/strong>Exhibit Halls A and B1 \u2013 San Diego Convention Center<\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>Discovery of a novel MAGEC2 epitope for TCR-T adoptive cell therapy from expanded T cell clones of TIL therapy products<br \/><strong>Authors: <\/strong>Andrew Ferretti, Adam Weinheimer, Dalena Nguyen, Olivia Pryor, Sarah Bertino, Qikai Xu, Yifan Wang, Els M.E. Verdegaal, Sjoerd H. van der Burg, Cagan Gurer, Gavin MacBeath<br \/><strong>Abstract Number: <\/strong>357<br \/><strong>Date &amp; Time: <\/strong>Friday, November 3, 2023, 9:00 a.m. \u2013 7:00 p.m. PT<br \/><strong>Location: <\/strong>Exhibit Halls A and B1 \u2013 San Diego Convention Center<\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>Overcoming tumor heterogeneity \u2013 Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1<br \/><strong>Authors:<\/strong> Ribhu Nayar, Shazad A Khokhar, Sonal Jangalwe, Sveta Padmanabhan, Nancy Nabilsi, Teagan Parsons, Jeffrey Coleman, Adam Hsiung, Chunghun Chang, Henry Tsai, Shehla Arain, Ariane Lozac\u2019hmeur, Andrew Nguyen, Jessica Rathbun, Qidi Yang, Ruey Pham, Sam Harris, Shardul Soni,\u00a0Tyler Danek, Katie Marshall, Amanda Jensen, Chris Riley, Livio Dukaj, Chandan Pavuluri, Alexander Cristofaro, Yun Wang, Erica Buonomo, Cagan Gurer, Antoine J Boudot, Shrikanta Chattopadhyay, Debora Barton, Gavin MacBeath<br \/><strong>Abstract Number: <\/strong>376<br \/><strong>Date &amp; Time: <\/strong>Saturday, November 4, 2023, 9:00 a.m. \u2013 8:30 p.m. PT<br \/><strong>Location: <\/strong>Exhibit Halls A and B1 \u2013 San Diego Convention Center<\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>Discovery of MAGE-A1-specific TCR-T cell therapy candidates to expand multiplex therapy of solid tumors<br \/><strong>Authors: <\/strong>Jenny Tadros, Nancy Nabilsi, Mollie Jurewicz, Akshat Sharma, Kenneth L. Jahan, Nicolas Gaspar, Kimberly M. Cirelli, Teagan Parsons, Shazad Khokhar, Shubhangi Kamalia, Sveta Padmanabhan, Drashti Shah, Badr Kiaf, Ribhu Nayar, Tary Traore, Victor Ospina, Antoine Boudot, Livio Dukaj, Jin He, Ryan Kritzer, Alexander Cristofaro, Chandan K Pavuluri, Emily Miga, Qikai Xu, Yifan Wang, Cagan Gurer, Gavin MacBeath<br \/><strong>Abstract Number: <\/strong>390<br \/><strong>Date &amp; Time: <\/strong>Saturday, November 4, 2023, 9:00 a.m. \u2013 8:30 p.m. PT<br \/><strong>Location: <\/strong>Exhibit Halls A and B1 \u2013 San Diego Convention Center<\/p>\n<p align=\"justify\">\n        <strong>Title: <\/strong>Non-clinical development of T-Plex component TSC-200-A0201: A natural HPV16 E7-specific TCR-T cell therapy for the treatment of HPV16-positive solid tumors<strong>\u00a0<\/strong><br \/><strong>Authors: <\/strong>Sonal Jangalwe, Badr Kiaf, Daniel C Pollacksmith, Shubhangi Kamalia, Sveta Padmanabhan, Hannah Bader, Tary Traore, Nivya Sharma, Victor Ospina, Debanjan Goswamy, Alok D Mohapatra, Shazad A Khokhar, Kimberly M Cirelli, Vivin Karthik, Kenneth L Jahan, Nicolas Gaspar, Livio Dukaj, Jin He, Ryan E Kritzer, Alexander Cristofaro, Chandan K Pavuluri, Amy Virbasius, Elisaveta Todorova, Tyler M Sinacola, Savannah G Szemethy, Kyra N Sur, Vandana Keskar, Chris Malcuit, Qikai Xu, Yifan Wang, Danielle Ramsdell, Kenneth Olivier, Antoine J Boudot, Ribhu Nayar, Gavin MacBeath\u00a0<br \/><strong>Abstract Number: <\/strong>364<br \/><strong>Date &amp; Time: <\/strong>Saturday, November 4, 2023, 9:00 a.m. \u2013 8:30 p.m. PT <br \/><strong>Location: <\/strong>Exhibit Halls A and B1 \u2013 San Diego Convention Center<\/p>\n<p align=\"justify\">\n        <strong>Title:<\/strong> Phase 1 trial of TSC-100 and TSC-101, Engineered T-Cell Therapies Targeting Minor Histocompatibility Antigens to Eliminate Residual Disease after Hematopoietic Cell Transplantation<br \/><strong>Authors:<\/strong> Monzr Al Malki, Alla Keyzner, Hyung C. Suh, Aasiya Matin, Erica Buonomo, Yun Wang, Nina Abelowitz, Jim Murray, Gavin MacBeath, Debora Barton, Shrikanta Chattopadhyay, Ran Reshef<br \/><strong>Abstract Number: <\/strong>682<br \/><strong>Date &amp; Time: <\/strong>Saturday, November 4, 2023, 9:00 a.m. \u2013 8:30 p.m. PT<br \/><strong>Location: <\/strong>Exhibit Halls A and B1 \u2013 San Diego Convention Center<\/p>\n<p align=\"justify\">A copy of the presentation materials will be added to the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2JIlcYtZUysMYI1da_5l-rq_uylsAGRPbW8_hfu0wLW2_HoXh5lRcIEvB6z_sg_t3133wadvKJO643QOm3NabecVfk1hQpXbnndUJscwsJ4O5ERaxpoArTRruvNJR-sqBWa4-TDwpQx19kblp79PqQ==\" rel=\"nofollow noopener\" target=\"_blank\">Events and Presentations<\/a>\u201d section of the Company\u2019s Investor Relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pqR6MaLpeef2CeLhfwZYmZmSNywuoVgwlbMXdYcNVyxtSQq0ER25WY7Ccfxg9qfB8F_oUeZM7UK_YcI9RsCG-g==\" rel=\"nofollow noopener\" target=\"_blank\">ir.tscan.com<\/a> once presentations have concluded.<\/p>\n<p align=\"justify\">\n        <strong>About TScan Therapeutics, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">TScan is a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The Company\u2019s lead TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. The Company is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. The Company has developed and continues to build its ImmunoBank, the Company\u2019s repository of therapeutic TCRs that recognize diverse targets and are associated with multiple HLA types, to provide customized multiplexed TCR-T therapies for patients with a variety of solid tumors.<\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Heather Savelle<\/strong><br \/>\n        <br \/>TScan Therapeutics, Inc.<br \/>VP, Investor Relations<br \/>857-399-9840<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0r81f-uNn44tKXkWBRetdQhZVOSuGwmsgFsz9OBVXFEXmr-jmaFPkvdUkdbwiuue9XCRrAC-_cey-BEU_Ernjgxli_z-XTMFzYagEmw_4Uo=\" rel=\"nofollow noopener\" target=\"_blank\">hsavelle@tscan.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Joyce Allaire<\/strong><br \/>\n        <br \/>LifeSci Advisors, LLC<br \/>Managing Director<br \/>617-435-6602<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l-2QO6nPBnTpysc2YsDCVrsDYs4uhIsoA6SciN2OnWPSmvhVjPSbX1JQ7mC-twjgAZtzfnNBB8l6jJyNQ8rXahoUbGNVgUkkrmY69o0_Wrdx_rPAX_GJ9c9TvU91VlcD\" rel=\"nofollow noopener\" target=\"_blank\">jallaire@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NjgzMWMwOWYtYzAxYi00ZDVlLThmYjctM2QyZDYxMTFjNmYzLTEyMTg2MjI=\/tiny\/TScan-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) &#8212; TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the acceptance of six abstracts at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting, being held from November 1-5, 2023, both in San Diego, CA and virtually. Presentation Details: Title: Product Characteristics and Clinical Trial Design for T-Plex, a Multiplexed, Enhanced T cell Receptor-Engineered T cell Therapy for Solid TumorsAuthors: Shrikanta Chattopadhyay, Antoine J Boudot, Ribhu Nayar, Hannah Bader, Andrew Ferretti, Tary Traore, Nancy Nabilsi, Jenny Tadros, Badr Kiaf, Yifan Wang, Victor Ospina, Alok Das Mahopatra, Zhonghua Zhu, Qikai &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-786508","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) &#8212; TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the acceptance of six abstracts at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting, being held from November 1-5, 2023, both in San Diego, CA and virtually. Presentation Details: Title: Product Characteristics and Clinical Trial Design for T-Plex, a Multiplexed, Enhanced T cell Receptor-Engineered T cell Therapy for Solid TumorsAuthors: Shrikanta Chattopadhyay, Antoine J Boudot, Ribhu Nayar, Hannah Bader, Andrew Ferretti, Tary Traore, Nancy Nabilsi, Jenny Tadros, Badr Kiaf, Yifan Wang, Victor Ospina, Alok Das Mahopatra, Zhonghua Zhu, Qikai &hellip; Continue reading &quot;TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-27T17:40:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting\",\"datePublished\":\"2023-09-27T17:40:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/\"},\"wordCount\":832,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/\",\"name\":\"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=\",\"datePublished\":\"2023-09-27T17:40:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting - Market Newsdesk","og_description":"WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) &#8212; TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the acceptance of six abstracts at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting, being held from November 1-5, 2023, both in San Diego, CA and virtually. Presentation Details: Title: Product Characteristics and Clinical Trial Design for T-Plex, a Multiplexed, Enhanced T cell Receptor-Engineered T cell Therapy for Solid TumorsAuthors: Shrikanta Chattopadhyay, Antoine J Boudot, Ribhu Nayar, Hannah Bader, Andrew Ferretti, Tary Traore, Nancy Nabilsi, Jenny Tadros, Badr Kiaf, Yifan Wang, Victor Ospina, Alok Das Mahopatra, Zhonghua Zhu, Qikai &hellip; Continue reading \"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-27T17:40:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting","datePublished":"2023-09-27T17:40:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/"},"wordCount":832,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/","name":"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=","datePublished":"2023-09-27T17:40:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyOTUzNSM1ODM0MjgyIzIyMDcwNjk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tscan-therapeutics-announces-upcoming-presentations-at-the-38th-society-for-immunotherapy-of-cancer-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/786508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=786508"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/786508\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=786508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=786508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=786508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}